Toxicology calls for papers / meetings & conferences

Call for Abstracts: Biannual Non-Clinical Statistics Conference

24-26 September 2012, Potsdam, Germany

Who should attend

Statisticians with an interest in the application of statistics to non-clinical areas of the drug development and production process.
Whether you work in the pharmaceutical industry, contract research organizations, academia, regulatory and other government bodies, this event will be relevant to you.

As announced, the third biannual Non-Clinical Statistics Conference will be held from September 24 – 26, 2012, in Potsdam, Germany. The program committee is currently organizing the traditional half-day workshop on a relevant topic on the first day of the conference.

We are also organizing the program for the 2012 Non-Clinical Statistics Conference. We would now like to invite you to submit your abstracts until May 31, 2012. We would encourage contributions in the following areas:

Statistical methods in functional genomics
Design and analysis of drug stability studies
Statistical evaluation of studies in regulatory toxicology
Bioassays
Analysis of in-vitro and in-vivo studies for new non-neoplastic compounds
Transfer of analytical methods
Pharmacological studies
Bayesian statistics in pre-clinical drug development
Incorporating pre-clinical results in clinical development
Other non-clinical applications

Please submit your abstracts to Richardus Vonk (see below).

Early registration is recommended, because the number of participants is limited. The conference fee will be €500 for industry participants and €200 for participants from academia and regulatory bodies. Students will pay €80. This fee includes the tutorial, beverages during the breaks, and lunch on September 25 and 26.

We are truly looking forward to meeting you at the non-clinical statistics conference. Please do not hesitate to contact me if you have any suggestions or questions regarding the yearly non-clinical statistics conference. We will keep you informed!

Richard Vonk
Dr. Richardus Vonk
Chair, AG Non-Clinical Statistics
German Region of the International Biometric Society.
www.ncs-conference.org

c/o Bayer Pharma AG
Head of Global Drug Discovery Statistics & Experimental Medicine Statistics
13342 Berlin
Tel: +49 30 468 14523
Fax: +49 30 468 94523
E-mail: richardus.vonk@bayer.com

Call for Abstracts: Annual Biomedical Research Conference for Minority Students

November 7-10, 2012 San Jose, California

Abstract Submission Deadline: Sept. 7, 2012

ABRCMS
American Society for Microbiology Education Department
1752 N Street, NW
Washington, DC 20036

Ph: 202-942-9348
Fax: 202-403-3513

Email:abrcms@asmusa.org

Call for Papers: Disrupting Pathways: Endocrine Disruptors and the Public Expertise of Health and Environmental Problems

We are pleased to invite you to submit a paper for the international research workshop "Disrupting pathways: Endocrine disruptors and the public expertise of health and environmental problems".

The workshop will be held in Paris the 14th and 15th of December 2012 and will gather both US and European participants. It will be organized around three main themes: a) the 70s and 80s early qualification of pesticides, PCB's, Dioxins or drugs as endocrine disruptors; b) the convergence between medical and environmental problems taking place in the 1990s; c) the regulatory initiatives from the late 1990s onward.

Travel and accommodation costs will be covered.

Please send proposals to the organizers Nathalie Jas (jas@ivry.inra.fr<mailto:jas@ivry.inra.fr>) and Jean-Paul Gaudilliere
(gaudilli@vjf.cnrs.fr<mailto:gaudilli@vjf.cnrs.fr>) by the 30th of June 2012.

In the past twenty years endocrine disurptors, the category as well as specific substances, have acquired a peculiar visibility both as targets for research and as objects of political debates. Issues like the impact of pesticides on the health of farmers, consumers and wild animals, the long term effect of persistant pollutants like PCBs which seems impossible to eliminate, the relations of xenostrogens to declining fertility and reproductive cancer incidence in humans, or the peculiar sensitivity of fetuses and developing organisms to chemicals mimicking the structures and roles of hormones are now discussed through an increasing number of publications and affairs perfectly illlustrated with the current debates on the need for a complete ban of Bisphenol A.

The processes, which have led to this situation and the recognition of what may be called an endocrine disruptors paradigm linking in unprecedented ways research, expertise, regulation, and social mobilizations - producing knowledge at the crossroad of reproductive medicine, toxicology, ecology, epidemiology and the social sciences - are complex and far from self-evident.

In the mid 1990s, the importance of man-made and man-realesed chemicals and pollutants modifying endocrine/reproductive functions in animals and humans was a motive of serious concern in small circles of experts, often associated with environmental, feminist or public health activism. It was a US phenomenon in the first place. A quarter of century later it is no longer possible to locate in such a precise manner the actors of endocrine disruptors networks. They are in laboratories, conservatories, and hospital services but also in the medias, health or environmental regulatory agencies, as well as in political institutions. They are present in the United States, Europe and the so-called emerging countries. In parallel with its diffusion, its contested but significant acceptance, the endocrine disruptor paradigm has crystalized a body of knowledge challenging traditional toxicology and views of adverse effects; a body focusing on low doses, multiple exposure, cumulative effects and sensibility of development periods.

The role of the proposed seminar is to explore the advent of this endocrine disruptors paradigm from the 70s onward, i.e. to understand how specific problems and substances have been redefined to become manifestation of endocrine disruption, to understand the dynamics of social movements and their role in the public expertise of these processes, to understand the transformation of regulation, to explore the impact the debates on endocrine disruptions have had on specific fields and disciplines in scientific research.

This seminar is an element in a more general research project of the trajectory of endocrine disruptors as scientific and political entities, which seeks to address both their generalization and the deep differences in their modes of existence in Europe, especially in France, and in the United States.

The workshop will take place in Paris. It will gather both US and European participants. It will be organized around three main themes: a) the 70s and 80s early qualification of pesticides, PCB's, Dioxins or drugs as endocrine disruptors; b) the convergence between medical and environmental problems taking place in the 1990s; c) the regulatory initiatives from the late 1990s onward.

Nathalie Jas
Research Fellow
RiTME Research Unit - INRA
65 Bd de Brandebourg
94205 Ivry-sur-Seine
France

Tel: + 33 (0)1 49 59 69 81

Call for Papers: Nanosafe 2012

After the success of Nanosafe 2008 and Nanosafe 2010, the next edition Nanosafe 2012 will be held from 13th to 15th November 2012 in Minatec, Grenoble, France .

Topics

Exposure assessment
Detection and identification
Toxicology
Environmental interactions
Nanomaterials release
Protection technology
Industrial production
Life Cycle Analysis
Ethics and societal issues
Commercial equipements
Risk management for OHS experts

Programme
The three-day programme for this conference will comprise:

-- Invited plenary lectures

G. Oberdörster (U. ROCHESTER), D. Pui (U. MINNESOTA), D. Brouwer (TNO), T. Nhuyen (NIST), F. Schuster (CEA), B. Nowack (EMPA), R. Muir (NANEUM). D. Bernard (ARKEMA), J. Rose (CEREGE), C. Engeman (UCSB) A. Grobe (U. STUTTGART). A. Grinbaum (CEA), F. Roure (FRENCH MINISTRY FOR ECONOMY, FINANCE AND INDUSTRY), A. Kishimoto (AIST, RISS), C. EMOND (U. MONTREAL), L. Golanski (CEA), O. Witschger (INRS), E. Drais (INRS).

-- Selected oral contributions

- Posters sessions

-- Panel discussions: Governance/ Toxicology/ The opinion of the civil society regarding nanomaterials

-- Exhibition of equipments related to safe production and use of nanomaterials

-- Satellite meetings: TITNT, TRIMATEC, NANOHOUSE

Papers will be presented in oral and poster sessions.

All accepted abstracts will be submitted online and published in a "Book of Abstract".

Full paper will be published after reviewing in the Journal of Physics: Conference Series.

Presentations will be available on the conference website

Deadline for abstracts: JULY 30, 2012

Call for Abstracts: International Symposium on Ocular Pharmacology and Therapeutics ISOPT Clinical 2013

March 7-10, 2013 Paris, France

The deadline for the submission of abstracts: December 4th, 2012.

Abstracts submitted after this deadline may be considered for presentation, but will not be included in the program book.

ISOPT will reconvene in Paris March 7 – 10 for our 10th symposium. Over the years, ISOPT has repeatedly shaped its form so it can accommodate to provide a collaborative atmosphere for clinicians, clinical trialists, pharma industry and regulatory officers. Our formed vision has been to increase knowledge and awareness of drug usage in ophthalmology reflecting innovations and their utilization in practice. In order to achieve this vision ISOPT is set to implement the following missions:

Educate via updating and sharing current and evolving treatment algorithms for practitioners.

Connect data arising from clinical studies to actual daily practice.

Facilitate innovation via panels and discussions of early and late “development related topics”.

We invite you to join us in Paris, and become a part of ISOPT, bring your own experience and insights of treating your patients, be exposed to the last two year clinical experience gained in major industry supported studies and be part of the efforts to reflect scientific data to clinical reality and patient care.

ISOPT has become famous for its informal atmosphere and the ability to meet experts and faculty leaders for “out of the lecture hall” discussions.

Whether your field of interest is in retinal diseases, inflammation, cornea and external diseases, glaucoma or basic science you may contribute and be part of the ISOPT spirit.

Call for Abstracts: International Congress of Toxicology 2013 (ICT 2013)

Translational Toxicology: From Basic Science to Clinical and Environmental Outcomes

Seoul, Korea, June 30 ~ July 4, 2013

Deadline for Abstract Submission: February 28, 2013

This congress will offer you many opportunities to exchange advanced knowledge on Toxicology. This year’s congress will be comprised of keynote lectures given by world-renowned scholars, in addition to symposiums, workshops, debates, as well as oral and poster sessions.